About Indegene Limited
Data last updated: 26 September 2026
Indegene Limited is a public limited company based in Bangalore, Karnataka, India. It specialises in consumer and professional services, a part of the broader travel and hospitality sector. Incorporated on 16 October 1998, the company has been in operation for over 28 years.
Registered with ROC Bangalore under CIN L73100KA1998PLC102040. Listed.
Capital: an authorised share capital of ₹80 Cr and a paid-up capital of ₹48.19 Cr. Formerly known as Ndegene Lifesystems Private Limited and Indegene Lifesystems Private Limited. It is led by directors including Pravin Udhyavara Bhadya Rao and Mark Frank Dzialga.
Last AGM: 26 June 2025. Financial statements filed for year ended 31 March 2025. Office: Aspen G4 3Rd Floor Manyata Embassy Business Park Outer Ring Road Nagavara, Bangalore, Karnataka, India – 560045.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹3,510.5 Cr, a growth of 23.64% compared to the previous year. The net worth stands at ₹3,138.7 Cr (up 20% YoY). Total assets are valued at ₹3,573.5 Cr (up 28.05% YoY).
The company has a workforce of approximately 4,628 employees as per the latest available data.
The company is associated with 1 brand - Indegene. As per MCA filings, the company has open charges of ₹85.5 Cr and satisfied charges of ₹25.45 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indegene.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressAspen G4 3Rd Floor Manyata Embassy Business Park Outer Ring Road Nagavara, Bangalore, Karnataka, India – 560045
-
IndustryTravel and Hospitality, Consumer Professional Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Indegene Limited
Indegene Limited has undergone 2 name changes throughout its history. The company was previously known as Ndegene Lifesystems Private Limited, and Indegene Lifesystems Private Limited. The current legal name is Indegene Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Indegene Limited | Current |
| Ndegene Lifesystems Private Limited | Previous |
| Indegene Lifesystems Private Limited | Previous |
CIN History of Indegene Limited
Indegene Limited has 4 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L73100KA1998PLC102040, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L73100KA1998PLC102040 | Current |
| U73100KA1998PTC102040 | Previous |
| U73100MH1998PTC269424 | Previous |
| U73100KA1998PTC032501 | Previous |
| U73100KA1998PLC102040 | Previous |
Associated Brands with Indegene Limited
Indegene Limited operates one associated brand: Indegene. These brands represent Indegene Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Suite solutions are provided for payers and healthcare providers. | indegene.com |
Competitors & Alternatives of Indegene Limited
Brands and companies operating in the same space as Indegene Limited include Zuellig Pharma, IntegriChain, Clinigen and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Healthcare access in Asia is enhanced by Zuellig Pharma. | Singapore, Singapore, Singapore | 1992 |
|
|
Inventory, order and customer relationship management solution for life science suppliers. | Philadelphia, United States, United States | 2005 |
|
|
Specialty medicines are supplied via clinical trials and access programs. | Burton-on-trent, United Kingdom, United Kingdom | 2010 |
|
|
Fully integrated cross-border services are delivered to global pharmaceutical organizations. | Brighton, United Kingdom, United Kingdom | 2001 |
|
|
Strategic consulting services are provided to life sciences companies. | Newton, United States, United States | 2008 |
|
|
Instruments for biotech, pharmaceutical, and biomedical sectors are manufactured. | Mumbai, India, India | 2002 |
|
|
Technology-based consultancy and product development services are provided. | Cambridge, United Kingdom, United Kingdom | 1995 |
Auditor Details of Indegene Limited
Indegene Limited is audited by BSR & CO LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BSR & CO LLP | Locked | Locked | Locked |
Complete auditor history for Indegene Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Indegene Limited
Indegene Limited is currently managed by 11 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Pravin Udhyavara Bhadya Rao
Also directs:
Indegene Limited, Computer Age Management Services Limited, Zensar Technologies Limited and 2 more
|
Director | 08 Jun 2022 | 4 Years 3 Months | Current |
|
Mark Frank Dzialga
Also directs:
Indegene Limited
|
Nominee Director | 16 Apr 2021 | 5 Years 5 Months | Current |
| Ashish Gupta | Director | 28 Apr 2022 | 4 Years 4 Months | Current |
|
Rajesh Bhaskaran Nair
Also directs:
Indegene Limited, Aarabhi Partners Consultants Llp
|
Director | 16 Oct 1998 | 27 Years 11 Months | Current |
|
Manish Gupta
Also directs:
Indegene Limited
|
Whole-Time Director | 11 Feb 2000 | 26 Years 7 Months | Current |
|
Sanjay S Parikh
Also directs:
Indegene Limited
|
Director | 29 Jan 2002 | 24 Years 7 Months | Current |
Financials of Indegene Limited FY 2025-26 filings available
Indegene Limited reported revenue of ₹3,510.5 Cr (up 23.64% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 3,510 | 2,839 | 2,590 | 2,306 | 1,665 | 966 | 643 |
| Revenue growth | +26.3% | +6.0% | +13.9% | +34.1% | +76.8% | +33.2% | +18.3% |
| EBITDA | 599 | 534 | 414 | 396 | 240 | 160 | 37.88 |
| EBITDA margin | +17.1% | +18.8% | +16.0% | +17.2% | +14.4% | +16.6% | +5.9% |
| Profit before tax | 525 | 539 | 459 | 363 | 226 | 195 | 13.68 |
| Net profit | 415 | 416 | 335 | 266 | 192 | 147 | (66.21) |
| Net profit margin | +11.8% | +14.7% | +12.9% | +11.5% | +11.5% | +15.2% | -10.3% |
| EPS (₹) | 16.68 | 16.98 | 15.17 | 12.01 | 938.81 | 954.66 | (40.25) |
| Balance sheet | |||||||
| Total assets | 3,574 | 2,791 | 2,026 | 1,738 | 935 | 417 | 476 |
| Net worth | 3,139 | 2,616 | 1,429 | 1,064 | 764 | 325 | 211 |
| Total debt | 144 | 102 | 490 | 502 | 65.75 | 51.38 | 168 |
| Cash & bank | 382 | 375 | 191 | 85.80 | 517 | 140 | 180 |
| Net working capital | 472 | 705 | 474 | 369 | 592 | 280 | 294 |
| Cash flow | |||||||
| Cash from operations | 651 | 442 | 508 | 130 | 297 | 172 | 22.27 |
| Cash from investing | (508) | (677) | (326) | (896) | (158) | (81.03) | (15.78) |
| Cash from financing | (82.60) | 288 | (66.20) | 333 | 233 | (132) | 136 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,063 | 1,003 | 942 | 804 | 761 | 756 | 720 | 687 |
| Revenue growth (YoY) | +39.7% | +32.8% | +30.8% | +17.1% | +12.5% | +12.3% | +7.0% | +8.0% |
| Other income | 29.00 | 10.80 | 19.40 | 19.70 | 22.10 | 25.60 | 37.70 | 21.40 |
| EBITDA | 174 | 143 | 160 | 141 | 155 | 148 | 132 | 126 |
| EBITDA margin | +16.4% | +14.3% | +16.9% | +17.5% | +20.4% | +19.5% | +18.3% | +18.4% |
| Depreciation | 44.10 | 41.80 | 39.60 | 23.40 | 21.60 | 20.70 | 20.00 | 19.40 |
| Interest | 6.40 | 7.20 | 4.60 | 3.80 | 3.70 | 3.10 | 3.20 | 4.00 |
| Profit before tax | 153 | 105 | 135 | 133 | 152 | 149 | 146 | 124 |
| Tax | 36.50 | 25.40 | 31.80 | 31.00 | 35.70 | 31.70 | 36.60 | 32.40 |
| Net profit | 116 | 79.70 | 103 | 102 | 116 | 118 | 110 | 91.70 |
| EPS (₹) | 4.81 | 3.30 | 4.26 | 4.23 | 4.82 | 4.88 | 4.55 | 3.80 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,221 | 1,094 | 1,046 | 1,006 | 837 | 511 | 334 |
| Revenue growth | +6.5% | +4.1% | +6.0% | +23.9% | +69.5% | +34.9% | +27.3% |
| EBITDA | 248 | 180 | 168 | 178 | 169 | 117 | 42.20 |
| EBITDA margin | +20.3% | +16.5% | +16.1% | +17.7% | +20.2% | +22.9% | +12.6% |
| Profit before tax | 281 | 238 | 181 | 177 | 170 | 159 | 45.50 |
| Net profit | 212 | 177 | 125 | 130 | 133 | 130 | 60.61 |
| Net profit margin | +17.4% | +16.2% | +11.9% | +13.0% | +15.9% | +25.4% | +18.1% |
| EPS (₹) | 8.81 | 7.57 | 6.21 | 5.88 | 663.50 | 882.67 | 211.33 |
| Balance sheet | |||||||
| Total assets | 2,230 | 1,974 | 1,035 | 881 | 720 | 290 | 368 |
| Net worth | 2,080 | 1,888 | 954 | 795 | 650 | 254 | 312 |
| Total debt | 69.80 | 27.20 | 38.00 | 51.10 | 43.80 | 23.00 | 46.90 |
| Cash & bank | 130 | 164 | 15.60 | 54.00 | 38.80 | 18.20 | 36.00 |
| Net working capital | 321 | 539 | 327 | 378 | 285 | 135 | 55.60 |
| Cash flow | |||||||
| Cash from operations | 346 | 129 | 176 | 81.90 | 38.20 | 53.30 | 89.60 |
| Cash from investing | (270) | (824) | (189) | (51.00) | (267) | (34.10) | (51.10) |
| Cash from financing | (62.60) | 717 | (15.80) | (16.90) | 245 | (37.10) | (18.50) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 341 | 368 | 290 | 307 | 256 | 267 | 287 | 282 |
| Revenue growth (YoY) | +33.3% | +38.1% | +1.2% | +8.9% | -1.2% | -2.1% | +10.3% | +8.1% |
| Other income | 33.90 | 6.10 | 22.60 | 17.50 | 32.10 | 35.20 | 22.30 | 22.40 |
| Total expenses | 280 | 265 | 252 | 236 | 219 | 227 | 235 | 235 |
| EBITDA | 60.20 | 103 | 37.70 | 70.60 | 36.70 | 39.60 | 51.90 | 46.40 |
| EBITDA margin | +17.7% | +28.0% | +13.0% | +23.0% | +14.4% | +14.8% | +18.1% | +16.5% |
| Depreciation | 11.40 | 10.90 | 9.50 | 8.60 | 7.30 | 6.90 | 6.50 | 6.20 |
| Interest | 2.70 | 3.10 | 1.80 | 2.00 | 1.70 | 1.50 | 1.60 | 1.60 |
| Profit before tax | 80.00 | 95.20 | 49.00 | 77.50 | 59.80 | 66.40 | 66.10 | 61.00 |
| Tax | 20.10 | 23.10 | 14.20 | 17.60 | 14.70 | 12.20 | 16.20 | 16.20 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,063 | 1,003 | 942 | 804 | 761 | 756 | 720 | 687 |
| Revenue growth (YoY) | +39.7% | +32.8% | +30.8% | +17.1% | +12.5% | +12.3% | +7.0% | +8.0% |
| Other income | 29.00 | 10.80 | 19.40 | 19.70 | 22.10 | 25.60 | 37.70 | 21.40 |
| EBITDA | 174 | 143 | 160 | 141 | 155 | 148 | 132 | 126 |
| EBITDA margin | +16.4% | +14.3% | +16.9% | +17.5% | +20.4% | +19.5% | +18.3% | +18.4% |
| Depreciation | 44.10 | 41.80 | 39.60 | 23.40 | 21.60 | 20.70 | 20.00 | 19.40 |
| Interest | 6.40 | 7.20 | 4.60 | 3.80 | 3.70 | 3.10 | 3.20 | 4.00 |
| Profit before tax | 153 | 105 | 135 | 133 | 152 | 149 | 146 | 124 |
| Tax | 36.50 | 25.40 | 31.80 | 31.00 | 35.70 | 31.70 | 36.60 | 32.40 |
| Net profit | 116 | 79.70 | 103 | 102 | 116 | 118 | 110 | 91.70 |
| EPS (₹) | 4.81 | 3.30 | 4.26 | 4.23 | 4.82 | 4.88 | 4.55 | 3.80 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 3,510 | 2,839 | 2,590 | 2,306 | 1,665 | 966 | 643 |
| Revenue growth | +26.3% | +6.0% | +13.9% | +34.1% | +76.8% | +33.2% | +18.3% |
| Other income | 72.00 | 107 | 170 | 58.00 | 25.89 | 67.26 | 3.98 |
| Total expenses | 2,912 | 2,305 | 2,175 | 1,910 | 1,425 | 806 | 605 |
| Employee cost | 2,198 | 1,815 | 1,652 | 1,465 | 1,014 | 536 | 370 |
| EBITDA | 599 | 534 | 414 | 396 | 240 | 160 | 37.88 |
| EBITDA margin | +17.1% | +18.8% | +16.0% | +17.2% | +14.4% | +16.6% | +5.9% |
| Depreciation | 126 | 80.20 | 76.10 | 59.80 | 33.45 | 25.55 | 19.34 |
| Interest | 19.30 | 22.00 | 49.40 | 31.30 | 5.96 | 6.96 | 8.84 |
| Profit before tax | 525 | 539 | 459 | 363 | 226 | 195 | 13.68 |
| Tax | 124 | 133 | 122 | 96.90 | 63.68 | 45.78 | 26.12 |
| Net profit | 415 | 416 | 335 | 266 | 192 | 147 | (66.21) |
| Net profit margin | +11.8% | +14.7% | +12.9% | +11.5% | +11.5% | +15.2% | -10.3% |
| EPS (₹) | 16.68 | 16.98 | 15.17 | 12.01 | 938.81 | 954.66 | (40.25) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 48.10 | 47.90 | 44.40 | 44.30 | 0.35 | 0.31 | 316 |
| Reserves & surplus | 3,090 | 2,567 | 1,385 | 1,020 | 764 | 324 | (105) |
| Shareholders' funds (net worth) | 3,139 | 2,616 | 1,429 | 1,064 | 764 | 325 | 211 |
| Minority interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.58 | 89.08 |
| Secured loans | 0.00 | 0.00 | 393 | 394 | 25.53 | 24.76 | 136 |
| Unsecured loans | 144 | 102 | 96.20 | 108 | 40.22 | 26.62 | 31.71 |
| Total debt | 144 | 102 | 490 | 502 | 65.75 | 51.38 | 168 |
| Total liabilities | 3,574 | 2,791 | 2,026 | 1,738 | 935 | 417 | 476 |
| Assets | |||||||
| Gross block | 2,354 | 1,096 | 995 | 863 | 271 | 191 | 259 |
| Net block | 1,812 | 678 | 646 | 664 | 138 | 85.91 | 119 |
| Capital work in progress | 11.80 | 3.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1,100 | 1,290 | 796 | 614 | 120 | 0.00 | 13.16 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 982 | 751 | 648 | 642 | 444 | 285 | 224 |
| Cash & bank balances | 382 | 375 | 191 | 85.80 | 517 | 140 | 180 |
| Loans & advances | 155 | 114 | 155 | 107 | 48.95 | 34.00 | 13.64 |
| Total current assets | 1,519 | 1,240 | 994 | 835 | 1,010 | 459 | 418 |
| Total current liabilities | 1,047 | 535 | 520 | 466 | 419 | 179 | 124 |
| Net working capital | 472 | 705 | 474 | 369 | 592 | 280 | 294 |
| Total assets | 3,574 | 2,791 | 2,026 | 1,738 | 935 | 417 | 476 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 241 | 189 | 73.60 | 506 | 133 | 174 | 31.01 |
| Net cash from operating activities | 651 | 442 | 508 | 130 | 297 | 172 | 22.27 |
| Net cash from investing activities | (508) | (677) | (326) | (896) | (158) | (81.03) | (15.78) |
| Net cash from financing activities | (82.60) | 288 | (66.20) | 333 | 233 | (132) | 136 |
| Net change in cash | 59.80 | 52.40 | 115 | (433) | 373 | (40.50) | 143 |
| Closing cash | 382 | 375 | 191 | 85.80 | 517 | 140 | 180 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +23.6% | +9.6% | +12.3% | +38.5% | +72.3% | +50.3% | +16.2% |
| EBITDA growth | +12.1% | +29.0% | +4.6% | +65.0% | +49.6% | +323.5% | -9.9% |
| PBT growth | -2.7% | +17.6% | +26.3% | +60.3% | +16.1% | +1326.8% | -46.8% |
| Net income growth | -0.5% | +24.3% | +25.9% | +38.6% | +30.5% | +9998.0% | - |
| Revenue CAGR (3Y) | +15.0% | +19.5% | +38.9% | +53.1% | +44.4% | - | - |
| EBITDA CAGR (3Y) | +14.8% | +30.6% | +37.2% | +118.7% | +78.8% | - | - |
| Profitability & leverage | |||||||
| Net income margin | +11.4% | +14.3% | +13.0% | +11.5% | +9.8% | +15.5% | -1.9% |
| Return on capital employed | +17.1% | +23.3% | +27.0% | +29.5% | +41.6% | +59.2% | 0.0% |
| Return on net worth | +13.9% | +20.1% | +27.0% | +29.1% | +34.9% | +133.9% | 0.0% |
| Debt / equity | 0.04 | 0.15 | 0.40 | 0.31 | 0.11 | 0.41 | 0.65 |
| Long-term debt / equity | 0.03 | 0.12 | 0.35 | 0.29 | 0.07 | 0.14 | 0.14 |
| Interest cover | 4.09 | 4.84 | 14.61 | 9.31 | 2.89 | 5.16 | 47.68 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.04 | 2.72 | 2.79 | 4.06 | 7.20 | 4.29 | 2.84 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | 4.05 | 4.06 | 4.01 | 4.25 | 4.56 | 3.80 | 4.10 |
| EPS (₹) | 16.68 | 16.98 | 15.17 | 12.01 | 938.81 | 954.66 | (40.25) |
| Dividend per share (₹) | 2.25 | 2.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 130.49 | 109.17 | 64.37 | 48.03 | 4,352.71 | 2,073.47 | (668.89) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 341 | 368 | 290 | 307 | 256 | 267 | 287 | 282 |
| Revenue growth (YoY) | +33.3% | +38.1% | +1.2% | +8.9% | -1.2% | -2.1% | +10.3% | +8.1% |
| Other income | 33.90 | 6.10 | 22.60 | 17.50 | 32.10 | 35.20 | 22.30 | 22.40 |
| Total expenses | 280 | 265 | 252 | 236 | 219 | 227 | 235 | 235 |
| EBITDA | 60.20 | 103 | 37.70 | 70.60 | 36.70 | 39.60 | 51.90 | 46.40 |
| EBITDA margin | +17.7% | +28.0% | +13.0% | +23.0% | +14.4% | +14.8% | +18.1% | +16.5% |
| Depreciation | 11.40 | 10.90 | 9.50 | 8.60 | 7.30 | 6.90 | 6.50 | 6.20 |
| Interest | 2.70 | 3.10 | 1.80 | 2.00 | 1.70 | 1.50 | 1.60 | 1.60 |
| Profit before tax | 80.00 | 95.20 | 49.00 | 77.50 | 59.80 | 66.40 | 66.10 | 61.00 |
| Tax | 20.10 | 23.10 | 14.20 | 17.60 | 14.70 | 12.20 | 16.20 | 16.20 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,221 | 1,094 | 1,046 | 1,006 | 837 | 511 | 334 |
| Revenue growth | +6.5% | +4.1% | +6.0% | +23.9% | +69.5% | +34.9% | +27.3% |
| Other income | 78.30 | 90.40 | 50.30 | 36.80 | 27.80 | 63.60 | 20.10 |
| Total expenses | 972 | 913 | 878 | 828 | 668 | 394 | 292 |
| Employee cost | 795 | 759 | 752 | 701 | 526 | 273 | 187 |
| EBITDA | 248 | 180 | 168 | 178 | 169 | 117 | 42.20 |
| EBITDA margin | +20.3% | +16.5% | +16.1% | +17.7% | +20.2% | +22.9% | +12.6% |
| Depreciation | 36.30 | 26.20 | 31.10 | 31.70 | 23.60 | 17.60 | 13.40 |
| Interest | 8.70 | 6.20 | 6.60 | 6.40 | 3.00 | 3.50 | 3.40 |
| Profit before tax | 281 | 238 | 181 | 177 | 170 | 159 | 45.50 |
| Tax | 69.50 | 57.20 | 42.70 | 46.40 | 37.20 | 26.90 | 13.80 |
| Net profit | 212 | 177 | 125 | 130 | 133 | 130 | 60.61 |
| Net profit margin | +17.4% | +16.2% | +11.9% | +13.0% | +15.9% | +25.4% | +18.1% |
| EPS (₹) | 8.81 | 7.57 | 6.21 | 5.88 | 663.50 | 882.67 | 211.33 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 48.10 | 47.90 | 44.40 | 44.30 | 0.40 | 0.30 | 316 |
| Reserves & surplus | 2,032 | 1,839 | 909 | 751 | 650 | 254 | (3.40) |
| Shareholders' funds (net worth) | 2,080 | 1,888 | 954 | 795 | 650 | 254 | 312 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 21.40 |
| Unsecured loans | 69.80 | 27.20 | 38.00 | 51.10 | 43.80 | 23.00 | 25.50 |
| Total debt | 69.80 | 27.20 | 38.00 | 51.10 | 43.80 | 23.00 | 46.90 |
| Total liabilities | 2,230 | 1,974 | 1,035 | 881 | 720 | 290 | 368 |
| Assets | |||||||
| Gross block | 253 | 183 | 175 | 187 | 149 | 99.40 | 72.50 |
| Net block | 113 | 52.80 | 56.10 | 78.30 | 72.00 | 40.60 | 31.30 |
| Capital work in progress | 11.80 | 3.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1,318 | 975 | 624 | 400 | 203 | 83.40 | 251 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 288 | 418 | 378 | 401 | 350 | 175 | 59.70 |
| Cash & bank balances | 130 | 164 | 15.60 | 54.00 | 38.80 | 18.20 | 36.00 |
| Loans & advances | 155 | 133 | 119 | 79.30 | 26.30 | 24.60 | 22.80 |
| Total current assets | 573 | 715 | 513 | 534 | 415 | 218 | 118 |
| Total current liabilities | 252 | 176 | 185 | 156 | 130 | 82.50 | 62.90 |
| Net working capital | 321 | 539 | 327 | 378 | 285 | 135 | 55.60 |
| Total assets | 2,230 | 1,974 | 1,035 | 881 | 720 | 290 | 368 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 35.20 | 13.20 | 41.80 | 27.80 | 11.60 | 29.50 | 9.50 |
| Net cash from operating activities | 346 | 129 | 176 | 81.90 | 38.20 | 53.30 | 89.60 |
| Net cash from investing activities | (270) | (824) | (189) | (51.00) | (267) | (34.10) | (51.10) |
| Net cash from financing activities | (62.60) | 717 | (15.80) | (16.90) | 245 | (37.10) | (18.50) |
| Net change in cash | 13.30 | 22.00 | (28.60) | 14.00 | 16.20 | (17.90) | 20.00 |
| Closing cash | 130 | 164 | 15.60 | 54.00 | 38.80 | 18.20 | 36.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +11.6% | +4.6% | +4.0% | +20.2% | +63.7% | +52.8% | +18.5% |
| EBITDA growth | +37.5% | +7.4% | -5.6% | +5.5% | +44.4% | +176.8% | -19.8% |
| PBT growth | +18.0% | +32.1% | +2.3% | +3.9% | +6.7% | +250.1% | -23.0% |
| Net income growth | +19.9% | +41.9% | -4.4% | -1.9% | +2.1% | +114.4% | +19.4% |
| Revenue CAGR (3Y) | +6.7% | +9.3% | +27.0% | +44.3% | +43.7% | - | - |
| EBITDA CAGR (3Y) | +11.7% | +2.3% | +12.9% | +61.5% | +47.5% | - | - |
| Profitability & leverage | |||||||
| Net income margin | +17.4% | +16.6% | +13.2% | +13.0% | +15.9% | +25.9% | +9.5% |
| Return on capital employed | +13.8% | +16.3% | +19.5% | +22.9% | +34.2% | +47.7% | +26.3% |
| Return on net worth | +10.7% | +12.8% | +15.8% | +18.0% | +29.4% | +96.4% | +67.5% |
| Debt / equity | 0.02 | 0.02 | 0.05 | 0.07 | 0.07 | 0.12 | 0.14 |
| Long-term debt / equity | 0.02 | 0.01 | 0.04 | 0.05 | 0.05 | 0.05 | 0.03 |
| Interest cover | 4.11 | 4.02 | 4.82 | 4.38 | 2.07 | 3.53 | 11.81 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 5.60 | 6.10 | 5.77 | 5.97 | 6.73 | 5.95 | 6.17 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | 3.45 | 2.75 | 2.69 | 2.68 | 3.19 | 4.35 | 6.09 |
| EPS (₹) | 8.81 | 7.57 | 6.21 | 5.88 | 663.50 | 882.67 | 211.33 |
| Dividend per share (₹) | 2.25 | 2.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 86.49 | 78.80 | 42.96 | 35.91 | 3,250.00 | 1,692.67 | (20.67) |
Shareholding Pattern of Indegene Limited
As per the shareholding pattern for the quarter ended Jun 2026, promoters hold 0.00%, foreign institutional investors hold 9.90%, domestic institutional investors hold 8.80%, retail and other public shareholders hold 81.30% of Indegene Limited.
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | |
|---|---|---|---|---|
| Promoters | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 100.00% | 100.00% | 100.00% | 100.00% |
Charges & Borrowings of Indegene Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2024 | Jp Morgan Chase Bank, N.A. | ₹15 Cr | Open |
| 29 Aug 2022 | Citi Bank N.A. | ₹15 Cr | Open |
| 26 May 2022 | Others | ₹10 Cr | Open |
| 20 Dec 2021 | The Hongkong and Shanghai Banking Corporation Limited | ₹15 Cr | Open |
| 21 Jun 2012 | Others | ₹30.5 Cr | Open |
Total charge records: 9 View all charges
Employees and EPFO Compliance at Indegene Limited
Indegene Limited has a workforce of 4,628 employees as of Apr 07, 2024.
Employee and EPFO history for Indegene Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Indegene Limited
GST registrations and filing compliance for Indegene Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Indegene Limited
Credit ratings, litigation, and regulatory alerts for Indegene Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Indegene Limited
MSME payment history for Indegene Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Indegene Limited
Corporate group structure for Indegene Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Indegene Limited
MCA filings and documents for Indegene Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Indegene Limited
Recent News on Indegene Limited
Frequently Asked Questions about Indegene Limited
Indegene Limited is an active public limited company in the travel and hospitality sector based in Bangalore, Karnataka, India. It was incorporated on 16 October 1998 (28+ years old) and is registered under CIN L73100KA1998PLC102040. The company has 4,628 employees.
Indegene Limited reported revenue of ₹3,510.5 Cr for FY 2025-26 (up 23.64% YoY) based on consolidated financials.
The current directors of Indegene Limited are:
- Pravin Udhyavara Bhadya Rao - Director
- Mark Frank Dzialga - Nominee Director
- Ashish Gupta - Director
- Rajesh Bhaskaran Nair - Director
- Manish Gupta - Whole-Time Director
- Sanjay S Parikh - Director
- Georgia Nikolakopoulou Papathomas - Director
- Jairaj Manohar Purandare - Director
- Krishnamurthy Venugopala Tenneti - Director
- Neeraj Bharadwaj - Director
- Jill Mary De Simone - Additional Director
The primary industry of Indegene Limited is travel and hospitality. The company specifically operates in consumer professional services. The company is currently active in this sector.
Yes, Indegene Limited is a listed company.
Indegene Limited can be reached at the registered office: Aspen G4 3Rd Floor Manyata Embassy Business Park Outer Ring Road Nagavara, Bangalore, Karnataka, India – 560045, or through the website indegene.com.